Indian Army Pharmaceutical Supply Procurement

Work Description - NA

The Department of Military Affairs, under the Ministry of Defence, is pleased to announce a tender opportunity for the supply of a comprehensive range of pharmaceutical products. This tender, identified by Bid Number GEM/2026/B/7930087, represents a critical procurement for the Indian Army. Bids will be accepted from **18-08-2026 at 1:02 PM** until **28-08-2026 at 2:00 PM**. The awarded contract will encompass the supply of a diverse list of medications including, but not limited to, Sucralfate 1000 mg 10 ml Oral Suspension, Oxetacaine 10 mg 10 ml Oral Suspension (bottle of 100 ml), Etophylline BP 84.7 mg and Theophylline IP 25.3 mg per ml 2 ml Injection, Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per actuation Aerosol (containing 200 actuations), Ipratropium Bromide Respirator Solution 500 mcg/2 ml Respule, Levo Salbutamol Sulphate 2.5 ml (containing 1.25 mg) Respule, Dextrose 50% 25 ml Injection, Dextrose Injection 25% 25 ml, Potassium Chloride 15% Injection, Sodium Bicarbonate 7.5% ampoule of 10 ml, Disodium Hydrogen Phosphate Syrup, and Cough Lozenges. The total estimated quantity for this tender is 4062 units across all specified items. This procurement is essential for ensuring the health and well-being of personnel within the Indian Army and is being managed by the Department of Military Affairs, located in Central Delhi.